Clinical biomarker-based biological aging and risk of benign prostatic hyperplasia: A large prospective cohort study.
Qiao HuangBing-Hui LiYong-Bo WangHao ZiYuan-Yuan ZhangFei LiCheng FangShi-Di TangYing-Hui JinJiao HuangXian-Tao ZengPublished in: Aging medicine (Milton (N.S.W)) (2024)
Biological aging is an independent and modifiable risk factor for BPH. We suggest performing active health interventions to slow biological aging, which will help mitigate the progression of prostate aging and further reduce the burden of BPH.